La transfusion de plaquettes n’est pas associée à une hausse de la morbidité ou de la mortalité en cardiochirurgie

[1]  R. D'Agostino Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[2]  S. McCluskey,et al.  The independent association of massive blood loss with mortality in cardiac surgery. , 2005 .

[3]  Stanley Lemeshow,et al.  Multiple Logistic Regression , 2005 .

[4]  B. Spiess,et al.  Transfusion of Blood Products Affects Outcome in Cardiac Surgery , 2004, Seminars in cardiothoracic and vascular anesthesia.

[5]  D. Spahn Strategies for transfusion therapy. , 2004, Best practice & research. Clinical anaesthesiology.

[6]  B. Spiess,et al.  Risks of transfusion: outcome focus , 2004, Transfusion.

[7]  S. McCluskey,et al.  The independent association of massive blood loss with mortality in cardiac surgery , 2004, Transfusion.

[8]  S. Body,et al.  Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes , 2004, Transfusion.

[9]  N. Heddle,et al.  Scientific Section , 2004, Transfusion.

[10]  H. Corwin,et al.  Is leukoreduction of blood components for everyone? , 2003, JAMA.

[11]  E. Vamvakas,et al.  Allogeneic blood transfusion and postoperative duration of mechanical ventilation: effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid , 2002, Vox sanguinis.

[12]  C. Tzeng,et al.  Cytokine release in febrile non‐haemolytic red cell transfusion reactions , 2002, Vox sanguinis.

[13]  F. Boehlen,et al.  Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? , 2001, Transfusion medicine.

[14]  E. Vamvakas,et al.  Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? , 2001, Blood.

[15]  H. Volk,et al.  Release of WBC‐derived IL‐1 receptor antagonist into supernatants of RBCs: influence of storage time and filtration , 2001, Transfusion.

[16]  A. Flahault,et al.  Thrombocytopenia in a surgical ICU. , 1999, Chest.

[17]  Mitchell H. Katz,et al.  Multivariable Analysis: A Practical Guide for Clinicians , 1999 .

[18]  M. Oz,et al.  Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. , 1998, Circulation.

[19]  M. Soop,et al.  Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? , 1996, Acta anaesthesiologica Scandinavica.

[20]  R C Smith,et al.  Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. S.P.I. Research Group. , 1991, Anesthesiology.

[21]  J. Schlesselman,et al.  Case-Control Studies: Design, Conduct, Analysis , 1982 .

[22]  P. Marik,et al.  Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. , 2005, Chest.

[23]  E. Moore,et al.  Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2. , 2000, Shock.